Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING LLC
RANDOX LABORATORIES

Autoantibody Targets Identified in Lupus Patients

By Labmedica International staff writers
Posted on 09 Dec 2013
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that can cause damage to multiple organ systems.

A microarray has been developed to identify cytokines, chemokines, and other circulating proteins as potential targets of the autoantibodies produced by SLE patients, and are implicated in inflammatory autoimmune disease and diseases of immune deficiency.

Scientists at Stanford University (CA, USA) and their colleagues from other institutes designed a nitrocellulose-surface microarray containing human cytokines, chemokines, and other circulating proteins and demonstrated that the array permitted specific detection of serum factor-binding probes. They used antibody binding assays and an indirect B cell-activating factor (BAFF) enzyme-linked immunoassay to detect autoantibodies.

Serum profiling from individuals with SLE revealed that among several targets, elevated immunoglobulin G (IgG) autoantibody reactivity to BAFF was associated with SLE compared with control samples. BAFF reactivity correlated with the severity of disease-associated features, including interferon (IFN)-α–driven SLE pathology. Of the other novel targets of autoantibodies they identified, the observed reactivity to the growth factors epidermal growth factor, (EGF), and somatotropin (HGH) were of particular interest.

Further screening of samples derived from individuals with SLE and other inflammatory autoimmune diseases revealed striking array reactivity to these and other growth factor targets, including various isoforms of fibroblast growth factor (FGF). The idea of an inverse relationship between inflammation- and growth factor-mediated pathways is an area of increasing interest in the field of inflammation.

The authors concluded that the implication of growth factor-targeted autoantibodies in the potential trade-off between tissue growth/repair and inflammation is one intriguing avenue to pursue. That serum factor-protein microarrays facilitated the detection of autoantibody reactivity to serum factors in human samples and that BAFF-reactive autoantibodies may be associated with an elevated inflammatory disease state within the spectrum of SLE. The study was published on November 25, 2013, in the Journal of Clinical Investigation.

Related Links:

Stanford University



KARL HECHT GMBH & CO KG
CELLAVISION AB
MEDLAB Asia

Channels

Genetic Tests

view channel
Image: For each chromosome, key SNPs are displayed above the chromosome and non-key SNPs below the chromosome, enabling users to determine the accuracy of haploblock calling. SNPs failed to be called are displayed as white points in the middle of the chromosome (Photo courtesy of Illumina).

Karyomapping Proposed as Alternative to Preimplantation Genetic Diagnosis for Evaluation of IVF Embryos

British researchers have suggested that karyomapping is a viable and cost-effective method for detecting a wide range of genetic diseases in IVF (in vitro fertilization) embryos. Preimplantation Genetic... Read more

Industry News

view channel
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems, Inc. (Tucson, AZ, USA) has announced its US Food & Drug Administration (FDA) final stage submission for premarket approval (PMA) of its companion diagnostic (CDx) immunohistochemistry... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
18 Mar 2015 - 20 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.